Get More With the Only Long-Term CGM
Established as a standalone company in 2016 with the purchase of Bayer Diabetes Care by PHC Holdings (formerly known as Panasonic Healthcare Holdings), Ascensia Diabetes Care is set to continue a proud legacy of innovations and firsts in diabetes management.
For more than 80 years, continuous research has allowed our diabetes care team to lead the way in blood glucose monitoring systems. These have been developed specifically to meet the needs of patients and along the way we have introduced many firsts.
While all CGM systems use transcutaneous sensors that are inserted into the skin and last 7-14 days, the Eversense sensor is inserted completely under the skin. The Eversense CGM system lasts up to 6 months — eliminating the hassle and discomfort of frequent sensor insertions. Simply put, it makes managing your diabetes so much easier.
Eversense gives you real-time glucose readings through a small sensor that’s placed just under the skin of your upper arm by an Eversense Inserter. The smart transmitter sits above the sensor, sending glucose data to your app.
The sensor is inserted by an Eversense Inserter in the upper arm and continuously measures glucose for up to 6 months.
Worn over the sensor, the transmitter wirelessly sends data to user’s mobile device; is removable** and rechargeable and provides unique on-body vibe alerts.
Displays and updates real-time glucose readings every 5 minutes with intuitive graphical design to show if you are in or out of range. Remote real-time monitoring capability - up to 5 people.†
